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Abstract
Background: The existing case fatality estimates of inpatient childhood pneumonia in developing countries are largely from
periods preceding routine use of conjugate vaccines for infant immunization and such primary studies rarely explore
hospital variations in mortality. We analysed case fatality rates of children admitted to nine Kenyan hospitals with
pneumonia during the era of routine infant immunization with Hib conjugate vaccine to determine if significant variations
exist between hospitals.
Methods: Pneumonia admissions and outcomes in paediatric wards are described using data collected over two time
periods: a one-year period (2007–2008) in nine hospitals, and data from a 9.25-year period (1999-March 2008) in one of the
participating hospitals. Hospital case fatality rates for inpatient pneumonia during 2007 to 2008 were modeled using a fixed
effect binomial regression model with a logit link. Using an interrupted time series design, data from one hospital were
analysed for trends in pneumonia mortality during the period between 1997 and March 2008.
Results: Overall, 195 (5.9%) children admitted to all 9 hospitals with pneumonia from March 2007 to March 2008 died in
hospital. After adjusting for child’s sex, comorbidity, and hospital effect, mortality was significantly associated with child’s
age (p,0.001) and pneumonia severity (p,0.001). There was evidence of significant variations in mortality between
hospitals (LR x2 = 52.19; p,0.001). Pneumonia mortality remained stable in the periods before (trend 20.03, 95% CI 20.1 to
0.02) and after Hib introduction (trend 0.04, 95% CI 20.04 to 0.11).
Conclusions: There are important variations in hospital-pneumonia case fatality in Kenya and these variations are not
attributed to temporal changes. Such variations in mortality are not addressed by existing epidemiological models and need
to be considered in allocating resources to improve child health.
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Introduction
Pneumonia is the leading cause of childhood deaths worldwide
accounting for an estimated 1.8 million deaths annually. [1] A
significant number of these deaths continue to occur in low income
countries and within hospitals in these settings. [2] While there are
summary and disease specific hospital death rates available for
developing countries data quality may be poor. [3] There are in
particular, significant gaps in understanding mortality, including
childhood pneumonia mortality. [4] First, unlike in developed
countries the potential variations in hospital pneumonia mortality
have not been studied in any detail in Kenya or similar settings
neither have potential causes of these variations been explored. [5,6]
Second, existing estimates mainly focus on geographical variations
and few studies have investigated temporal variations in hospital
death rates. In order to be convincing, investigations of temporal
variations for pneumonia mortality must account for major policy
interventions targeting disease specific mortality, for example
introduction of pneumonia vaccines in routine use. During the past
decade, two pneumonia vaccines have been introduced in routine
use in Kenya: the H. influenzae Type B (Hib) vaccine in 2001 and,
after the study now reported, pneumococcal conjugate vaccine in
2012. Data describing pneumonia outcomes in low-income
countries (LICs) in the era after vaccine introduction are sparse.
One important application of data generated from studies
investigating variations in pneumonia death rates would be in
reviewing epidemiological models currently being used for
decision making. The present decision making models assume
that pneumonia outcomes are relatively homogeneous. For
example an international analysis of pneumonia vaccination cost
effectiveness including 72 developing countries was able to identify
only four published studies on which to base its severe pneumonia
case fatality rate. [7] Such simplifying assumptions are partly
justified by lack of data but their impact needs to be examined.
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Better data on and understanding of pneumonia mortality are
therefore important to improve models that help direct current
and future resource use in health and as a means to understand
health system performance and direct efforts to areas where
performance is poor.
The purpose of the analysis presented here was to explore two
scenarios in which variations in hospital pneumonia mortality rates
could occur. Firstly using data collected simultaneously from nine
hospitals we examined whether pneumonia mortality varies
significantly by hospital. Outcomes were measured using vital
information recorded in paediatric medical notes during a one-
year period. Secondly, and using time series data collected in one
hospital over a 9.25-year period, we conducted further analysis to
identify evidence of temporal variation in pneumonia mortality
within the hospital over time. Variations in death rates within
hospital over time could be explained by several factors including
major policy changes, changes in practice or organization of care.
One such policy change implemented during the time period
covered by our temporal analysis (1998 to March 2007) and
relevant for pneumonia outcomes was introduction of Hib vaccine
into routine use in Kenya in 2001. Using interrupted time series
analysis we investigated pneumonia mortality over time while
accounting for the introduction of Hib vaccine during the time
horizon of our analysis.
Methods
Ethics Statement
During admission to Kilifi District Hospital written informed
consent to enroll patients in ongoing studies is obtained from
parents or guardians of paediatric admissions. In the remaining
eight sites ethical approval was granted for confidential abstraction
of data from archived case records without individuals’ consent
due to the retrospective design. The Kenya Medical Research
Institute/National Ethical Review Committee approved the study.
Study Subjects
We obtained data on paediatric admissions and outcomes in
nine Kenyan District hospitals. In one hospital data were collected
as part of ongoing, prospective clinical surveillance (Kilifi District
Hospital, H9) and in eight sites (H1 to H8) data were obtained
during conduct of a multicenter trial aimed at improving quality of
inpatient paediatric care (described in full elsewhere [8]). All
admissions to the nine participating hospitals H1–H9, aged 2 to 59
months admitted with acute illnesses from March 2007 to March
2008 (inclusive) were eligible for inclusion in the analysis. A
random sample was drawn from these eligible admissions in eight
hospitals (H1–H8) while in H9 all eligible children were included
in the study. The sampling in the eight hospitals (H1–H8) was
based on randomly selecting calendar dates from two consecutive
6-month periods in each hospital. All admissions on the sampled
dates were included in the study using each hospital’s admission
rate to adjust the proportion of selected dates to yield approxi-
mately 400 medical records per hospital during each 6-month
period (Table 1). For this particular analysis the inclusion criteria
was admission with any pneumonia diagnosis.
Study Sites
Cross-sectional data. Data from the multicenter study were
obtained from 8 rural district hospitals (H1 to H8) from four of
Kenya’s eight provinces. The characteristics of these hospitals and
the interventions received have been described previously. [8,9] In
brief these eight hospitals spanned highland and semi-arid areas
with low risk of malaria transmission and areas near Lake Victoria
with moderate to high risk of malaria transmission. Sites also
varied in estimated ante-natal HIV prevalence (from ,5% to
.10% in 2005), estimated infant mortality rate (approximately 40
to over 100 per 1,000 in 2005) and hospital size (996 to 4738
paediatric admissions in 2005). [8] Data from the study used in the
current analysis were collected from these sites and from Kilifi
District Hospital (described below) during the first 12 months
(March 2007 to March 2008) of the 18 month intervention period
when all sites were expected to use national pneumonia case
management guidelines.
Kilifi District hospital. Kilifi District Hospital (KDH) is
located in a rural area along the Kenyan coast with clinical and
laboratory surveillance undertaken on all pediatric admissions
since 1998. [10] The hospital serves a predominantly poor
population and has a research center -Kenya Medical Research
Institute’s Center for Geographic Medicine Research (CGMRC) -
located within it. Approximately 5000 children are admitted
annually to the 42-bed paediatric ward. [11] The hospital is
located in a malaria endemic area and the current antenatal HIV
prevalence is approximately 4.7%. [12] All paediatric admission
episodes to KDH are now prospectively documented using an
electronic medical record which contains information on clinical
assessment, treatment and discharge outcomes. As part of the
multi-centre study a paper paediatric admission record was
introduced into the eight hospitals described above to capture
similar information to that available from the electronic medical
record at KDH.
Data quality. Missing data is commonly encountered within
data sets collected in routine clinical settings as in our study. This is
less of a problem in settings with an electronic medical record
system such as Kilifi District Hospital (H9). During this study we
attempted to improve quality of routine data from the eight
remaining hospitals through introducing structured paediatric
admission records (PAR) for documenting childhood admission
episodes in hospitals (H1–H8). Details of the development, piloting
and introduction of the PAR have been presented previously.
[8,13] Although the tool was widely accepted by clinicians and
greatly improved documentation of childhood illnesses in Kenyan
District Hospital settings there were disparities in PAR use among
clinicians and across hospitals explaining the differences in
completeness of documentation of clinical features of illness in
data collected in the eight hospitals- H1 to H8.
Study outcome. The main outcome in this analysis was
pneumonia mortality. The pneumonia classification adopted for
our analysis was based on WHO pneumonia guidelines (Box S1).
Paediatric clinical health workers within each hospital were
trained to apply pneumonia severity classification in diagnosis
and management of acute respiratory illness as outlined in national
guidelines adapted from WHO recommendations. The primary
cause of death was assigned at the analysis stage. Admissions with
severe malnutrition (visible wasting) and/or meningitis were
excluded from analysis because these two conditions are more
likely to be assigned as primary causes of death even in the
presence of pneumonia. Where children presented with both non
severe pneumonia, a condition with very low mortality in the
presence of biomedical treatment, and malaria or diarrhea and
dehydration the latter diagnosis was assigned as the primary cause
of death. Otherwise, for children with a diagnosis of severe or very
severe pneumonia the presenting pneumonia diagnosis was
considered the primary cause of inpatient death. The primary
cause of death could not be determined in sixteen children with
unclassified pneumonia who were therefore excluded from the
pneumonia mortality analysis.
Inpatient Childhood Pneumonia Mortality
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Cross-sectional analysis of pneumonia mortality. Cross-
sectional data collected on admission and at death or discharge
from admissions to all nine hospitals between April 2007 and
March 2008 were used for this analysis. We determined that the
data available for our analysis would allow us to estimate
pneumonia case fatality within each hospital with adequate
precision for both hospitals reporting high and low mortality
rates. For hospitals with the lowest pneumonia case fatality
(approximately 4%) we required at least 369 observations per site
to estimate mortality with a precision of 62%. On the other hand,
in hospitals with mortality rates of 10% or above at least 138
observations per hospital would allow estimation of inpatient
pneumonia case fatality with precision of 65%.
Co-morbid illnesses including clinical diagnoses of malaria and
diarrhoea and/or dehydration, age and gender of child were
obtained from the medical records and all these data were merged
with the discharge vital statistic information, indicating whether a
child died during admission or was discharged alive. Patient level
data on HIV status were not routinely available. Data cleaning
and analysis was conducted using STATA version 11 (StataCorp,
Tx USA). The distribution of pneumonia cases by reported illness
severity, age, gender and common co-morbidities was described
within each hospital. Crude and adjusted case fatality rates for
pneumonia were estimated within each hospital. To do this a
binomial regression model with a logit link, including a fixed effect
for hospitals, was used to estimate odds ratios for pneumonia
mortality within each hospital adjusted for age, gender, and
malaria or diarrhea comorbidity. Predicted probabilities repre-
senting average pneumonia case fatality in each hospital were
obtained from the regression model. The assessment of significant
variation in pneumonia case fatality was conducted using
likelihood ratio tests.
We conducted a sensitivity analysis to assess the impact of
including H9 in the analysis for two reasons. First, unlike the other
hospitals H9 has a research center based within it and this center
has been conducting research on common childhood illnesses
within the hospital’s paediatric unit since 1989. The quality of data
available and possibly quality of care in this hospital therefore
differed from that in the remaining District Hospitals. Second, this
hospital contributed around 40% of the total observations in the
final regression model used to estimate adjusted pneumonia
mortality and associated variations in mortality. We employed user
defined weighting in the regression analysis for data from H9 and
conducted regressions using five different increasing weights: 0
(equivalent to exclusion of KDH data from analysis), 0.3, 0.5 and
0.8. These regressions were compared to the base case (equally
weighted) analysis which was equivalent to a weight of 1.0.
Time Series Analysis of Trends in Pneumonia Mortality
Data collected from January 1999 to March 2008 at KDH were
aggregated by time point and analysed by specifying a segmented
linear regression model with the mean monthly pneumonia case
fatality rate as the unit of analysis. Pneumonia mortality trends
during the period were examined using interrupted time series to
explore the potential impact of nationwide Hib vaccine introduc-
tion in November 2001 on pneumonia mortality. To account for
the lag in vaccine effect our segmented regression model excluded
the year of Hib introduction and one year post-vaccine
introduction (November 2001–November 2003).
In addition to the outcome of pneumonia mortality, the
regression model included terms for Hib vaccine introduction,
and secular trends for the time periods before and after Hib
introduction. The resulting model coefficients represented pneu-
monia mortality trends in the two analysis periods and the change
in level of mortality post Hib introduction based on the approach
proposed by Wagner and colleagues. WHO case definition of
pneumonia, severe pneumonia and very severe pneumonia for
children aged 2 to 59 months.
Serial autocorrelation between the error terms for case fatality
rates over time was tested using the Durbin-Watson statistic and
the model controlled for autocorrelation by correcting for first
order autoregressive effects. Seasonal variations in pneumonia
mortality were demonstrated, with higher case fatality rates
occurring from April to June. These seasonal effects were
accounted for by including indicator terms representing each
calendar month in the regression model.
Table 1. Admissions aged 2–59 months at 9 Kenyan District Hospitals from March 2007 to March 2008 and characteristics of those
with pneumonia diagnosis.
H1 H2 H3 H4 H5 H6 H7 H8 H9 Overall
Number of
admissions
515 555 537 518 501 363 558 507 2547 6601
Admissions with
any pneumonia
diagnosis, n*(%)
211(41.0) 378(68.1) 241(44.9) 285(55.0) 111(22.2) 195(53.7) 244(43.7) 264(52.1) 1443(56.7) 3372(51.1)
Pneumonia 55(26.1) 76(20.1) 89(36.9) 94(33.0) 9(8.1) 24(12.3) 37(15.2) 51(19.3) 562(38.9) 997(29.6)
Severe
pneumonia
111(52.6) 192(50.8) 107(44.4) 145(50.9) 12(10.8) 91(46.7) 84(34.4) 154(58.3) 612(42.4) 1508(44.7)
Very severe
pneumonia
35(16.6) 100(26.5) 39(16.2) 35(12.3) - 11(5.6) 18(7.4) 37(14.0) 269(18.6) 544(16.1)
No
classification{
10(4.7) 10(2.6) 6(2.5) 11(3.9) 90(81.1) 69(35.4) 105(43.0) 22(8.3) - 323(9.6)
Median age in
months (IQR)
14(7–25 11(7–20) 12(7–24) 12(7–24) 14.4(8–28) 10(6–17) 12(7–24) 11(6–20) 16(8.3–29) 12(6–23)
Male 103(48.8) 213(56.4) 127(52.7) 138(48.4) 57(51.4) 95(48.7) 108(44.6) 138(52.3) 814(56.4) 1793(53.2)
*n represents denominator for the pneumonia classifications and child’s sex presented below.
{represents a pneumonia diagnosis in which the clinician failed to classify severity as pneumonia, severe pneumonia or very severe pneumonia.
H9 is Kilifi District hospital where data is collected in a prospective on-going surveillance of all inpatients.
doi:10.1371/journal.pone.0047622.t001
Inpatient Childhood Pneumonia Mortality
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Results
Cross-sectional data collected from all nine hospitals were
available for 3 372 pneumonia admissions from March 2007 to
March 2008 (1 443 from KDH and 1 929 from the remaining 8
hospitals). There were an additional 15 739 pneumonia cases
drawn from 28 160 admissions to KDH between January 1999
and February 2007 and used for the time series analysis presented
at the end of this results section.
Participants’ Characteristics
In the one-year cross-sectional mortality analysis, approximately
50% of the patients admitted across hospitals were male (Table 1).
Overall, the median age of pneumonia admissions was 12 months
(interquartile range 6 to 23) varying across the hospitals from 8 to
13.5 months (Kruskal-Wallis x2, 8 d.f = 38.1, p = 0.0001). In the
time series data for children admitted to KDH (H9) patient
characteristics did not change substantially between January 1999
and February 2007 (data not shown) or differ significantly from
that of children admitted in 2007–2008 shown in Table 1.
a) Cross-sectional Analysis
Pneumonia case management. Approximately 90% of
3372 children with a pneumonia diagnosis across all hospitals in
2007–2008 had a severity classification based on WHO recom-
mendations. Very severe pneumonia accounted for 544 (16.1%)
cases, severe pneumonia for 1508 (44.7%) and pneumonia
accounted for 997 (29.6%) of all pneumonia cases (Table 1).
The remaining 323 (9.6%) children were not assigned a severity
classification for pneumonia. Failure to assign a severity classifi-
cation varied across hospitals and was observed in between 35%
and 81% of admissions to H5, H6 and H7, and less than 10% of
admissions to H1 to H4 and H8. All children admitted with
pneumonia to H9 were assigned a severity classification (Table 1).
Inpatient pneumonia mortality. Among the 3372 children
admitted with pneumonia from March 2007–March 2008 no
information was available on hospitalization outcome of 53 (1.6%)
children. Of the remaining 3 319 children with pneumonia 195
(5.9%) children died. The overall case fatality rates for pneumonia,
severe pneumonia and very severe pneumonia were 19 out of 997
(1.91%), 72 out of 1508 (4.77%) and 82 out of 544 (15.07%),
respectively. The overall risk of death among children admitted
with very severe pneumonia was significantly higher than for
severe pneumonia (15.07% versus 4.77%, risk ratio = 3.13, 95%CI
2.32 to 4.24, p,0.001).
The unadjusted overall pneumonia case fatality rates in the nine
hospitals ranged from 3.7% in H2 to 13.9% in H5 (Table 2). After
adjusting for the effect of age, gender, and common co-morbidities
including malaria and diarrhoea/dehydration the case fatality
rates varied significantly between hospitals (LR x2 = 52.19;
p,0.001), ranging from 3.1% (95%CI, 0.9 to 5.4) in H7 to
13.2% (95%CI, 6.9 to 19.5) in H5 (Table 2).
In the adjusted analysis, age, diarrhea co-morbidity and
pneumonia severity showed statistically significant associations
with pneumonia mortality (Table 3). Compared to infants (2 to 11
months) with a case fatality rate of 8.8%, the odds of mortality
were approximately 60% lower for children aged 12–24 months
(3.5%) and 25–59 months (3.3%), p,0.001. A co-morbid diarrhea
diagnosis was independently associated with higher fatality in the
adjusted analysis (Odds Ratio = 1.50, 95% CI 1.04–2.15,
p = 0.028, Table 3). Increasing pneumonia severity was also
associated with higher case fatality rates. Compared to severe
pneumonia admissions with children with very severe pneumonia
had the highest risk of death (OR 9.17, 95% CI 5.37–15.67)
followed by severe pneumonia (OR 2.22, 95% CI 1.30–3.79).
Sensitivity analysis. Inclusion of data from H9 did not
change the direction of any significant effect for the covariates
used to explain pneumonia mortality in the fixed effects model.
(Table S1) Regardless of the weight assigned to hospital H9 data,
the magnitude of effect for age (12–24 months) on mortality was
consistent as was the effect of severe pneumonia classification. The
effect of age (25–29 months), very severe pneumonia classification
and malaria co-morbidity increased progressively with increasing
importance weight of H9 data.
b) Time Series Analysis of Pneumonia Mortality at KDH
The data available from Kilifi District Hospital covered a period
of 9.25 years representing 111 monthly time points. During this
period a total of 17 179 admissions were diagnosed with
pneumonia and the average monthly mortality rate was 6.6%
over the entire period. In January 1999, the estimated mortality
rate was 6.0% (95% CI, 3.6 to 8.4%). The trend in pneumonia
mortality remained constant between 1999 and November 2001
(trend 20.03, 95% CI 20.1 to 0.02, p = 0.36) when the Hib
vaccine was introduced (Figure 1). There was a statistically
insignificant decline in pneumonia case fatality rate (20.9, 95% CI
23.9 to 2.1, p = 0.55) at the end of 2003, two years after Hib
introduction. No significant trend in pneumonia deaths was seen
between November 2003 and the end of the study (trend 0.04,
95% CI 20.04 to 0.11, p= 0.35).
Discussion
The high mortality attributed to pneumonia in childhood has
been reported in numerous publications, [14,15] but surprisingly
there is very little systematic analysis of pneumonia deaths in hospital
in developing countries. This study is among the first formal
multicenter comparisons of inpatient pneumonia mortality under-
taken in the Hib vaccine era in Africa and similar low income
settings. Importantly, the study explores temporal changes in one
site as a possible explanation to the observed variation in hospital
mortality.Our study demonstrated significant variations in inpatient
paediatric pneumonia mortality rates, with the adjusted mortality
rates varying by up to three-fold across hospitals. Although we could
examine only one site we found considerable consistency in
mortality rates over a period spanning 9.25 years suggesting that
temporal variations may not explain the observed cross-sectional
variation in inpatient pneumonia mortality.
What might explain variability in mortality? Several risk factors
for mortality, including co-existent malnutrition or HIV, could
explain the observed between hospital variations. A clear impact of
HIV on childhood mortality in sub-Saharan Africa has become
apparent in recent years especially in southern and eastern African
countries, [16] and malnutrition is considered a contributory
factor in many childhood deaths. [17] Although children also
diagnosed with severe malnutrition were excluded from the study
it is possible that prevalence of lesser degrees of malnutrition that
could not be identified in our study will vary and influence case
fatality rates. Unfortunately individual patient HIV information
was not routinely collected during the study period. Estimates of
antenatal HIV prevalence in areas served by hospitals were
available but were not used in our analysis because such hospital-
level effects are effectively captured in the hospital estimates
derived from fixed effects models. Conversely, it is noteworthy that
in a rural Zambian hospital pneumonia mortality was not
significantly affected by HIV infection in children presenting with
Inpatient Childhood Pneumonia Mortality
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and appropriately treated for acute lower respiratory infection.
[18].
Our findings from analysis of time series data from Kilifi
confirm the seasonality of pneumonia mortality in Kilifi agreeing
with previously demonstrated seasonal patterns for LRTI
incidence within the same setting. [19] After accounting for the
seasonality in pneumonia case fatality, data from Kilifi demon-
strated a non-significant decline in pneumonia mortality post-Hib
introduction but no evidence of an overall trend in pneumonia
mortality over a 9.25-year period. Cowgill et al reported significant
reductions in the incidence of invasive Haemophilus influenzae
disease, a major cause of bacterial pneumonia, in Kilifi district
in 2004, three years after introduction of routine Hib vaccination.
[11] Pneumonia case fatality rates remained relatively stable
despite some evidence for a decline in HIV prevalence over this
period. [12] In the multivariate analysis, we found that the odds of
pneumonia deaths outside the infant age group was approximately
Table 2. Outcome for paediatric admissions with pneumonia in 9 Kenyan district hospitals.
Pneumonia deaths
(CFR)
Unadjusted
CFR (95%CI)
Adjusted CFR {
(95% CI)
Hospital Pneumonia
Severe
pneumonia
Very severe
pneumonia No classification Overall Overall
H1 1(1.9) 10(9.7) 9(26.5) 1(14.3) 10.7(6.7,15.8) 9.5(5.5,13.4)
H2 1(1.3) 6(3.1) 7(7.0) 0 3.7(2.0,6.2) 3.9(1.9,5.8)
H3 3(3.5) 4(3.8) 6(15.4) 0 5.5(3.0,9.2) 5.6(2.6,8.5)
H4 2(2.1) 21(14.6) 9(25.7) 1(9.1) 11.6(8.1,15.9) 12.1(8.4,15.8)
H5 1(12.5) 1(8.3) 0 13(14.8) 13.9(8.0,15.9) 13.2(6.9,19.5)
H6 1(8.7) 4(4.9) 1(9.1) 4(6.3) 6.1(3.1,10.7) 6.6(2.9,10.3)
H7 0 3(3.7) 3(17.7) 1(0.97) 3.0(1.2,6.0) 3.1(0.9,5.4)
H8 4(7.8) 11(7.2) 6(16.2) 2(9.1) 8.8(5.6,12.8) 8.7(5.3,12.1)
H9 5(0.89) 12(2) 41(15.4) 0 4.0(3.1,5.2) 4.0(3.0,5.0)
*Case fatality rate.
{Case fatality rate adjusted for patient’s age, gender, malaria & diarrhoea/dehydration comorbidity.
doi:10.1371/journal.pone.0047622.t002
Table 3. Effect of age, sex, and comorbidity on pneumonia mortality adjusted for hospital.
Died (%) Survived (%) Unadjusted OR (95% CI) Adjusted OR (95% CI)
Age group
2–11 months 135 (8.8) 1400 (91.2) 1.00 1.00
12–24 months 34 (3.5) 952 (96.5) 0.41 (0.31–0.54) 0.39 (0.25–0.58)
25–59 months 26 (3.3) 772 (96.7) 0.42 (0.32–0.56) 0.42 (0.27–0.67)
Sex
Female 90 (6.2) 1353 (93.8) 1.00 1.00
Male 97 (5.5) 1665 (94.5) 0.89 (0.74–1.12) 0.87 (0.64–1.19)
Pneumonia severity
Pneumonia 19 (9.1) 966 (98.1) 1.00 1.00
Severe pneumonia 72 (4.9) 1412 (95.1) 2.59 (1.55–4.33)
Very severe pneumonia 82 (15.2) 457 (84.8) 9.12 (5.47–15.21) 9.17 (5.37–15.67)
Pneumonia without severity
classification
22 (7.1) 289 (92.9) 3.81 (2.06–7.25) 2.54 (1.12–5.80)
Malaria
No malaria 170 (6.0) 2666 (94) 1.00 1.00
Moderate malaria 4 (1.9) 202 (98.1) 0.31 (0.11–0.85) 0.47 (0.16–1.36)
Severe malaria 18 (9.1) 180 (90.9) 1.57 (0.94–2.61) 1.15 (0.65–2.04)
Malaria without severity classification 3 (3.8) 76 (96.2) 0.62 (0.19–1.98) 0.44 (0.12–1.55)
Diarrhea/dehydration
No 135 (5.1) 2543 (94.9) 1.00 1.00
Yes 60 (9.2) 590 (90.8) 1.47 (1.17–1.86) 1.50 (1.04–2.15)
doi:10.1371/journal.pone.0047622.t003
Inpatient Childhood Pneumonia Mortality
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half that of infants. Similar declines in risk of pneumonia mortality
with increasing age have been reported previously. [14].
While interpreting the interrupted time series analysis in our
study it is important to consider several factors. First, the primary
aim of this analysis was not to determine effectiveness of Hib
vaccine in preventing pneumonia mortality (i.e. change in level of
the two segments of the time series). Instead the analysis intended
to determine pneumonia mortality trend (i.e. slopes of the two
segments) among children hospitalized with severe pneumonia
while accounting for vaccine introduction during the analysis
period. Demonstrating vaccine effectiveness would require incor-
porating outpatient pneumonia incidence and outcomes data and
is best implemented using community based surveillance studies.
Second, we considered possible alternative explanations for the
lack of a significant vaccine effect on severe inpatient pneumonia
mortality including low vaccination coverage. The estimated
vaccine coverage within Kilifi district at the point of vaccine
introduction was relatively high- 87% at 12 months of age.
(Cowgill) This coverage reduces after the infancy period but the
average national coverage at 12–23 months of age during 2008/09
was 77%. (KDHS).
Our study applied the WHO definition of severe pneumonia
which captures a broad group of critically ill children with
respiratory distress, including metabolic acidosis, lowering its
sensitivity. We observed a variable effect of co-morbid illnesses on
pneumonia mortality. While children with diarrhea comorbidity
had a higher risk of mortality admissions with malaria comorbidity
did not. Interestingly over the period spanning deployment of Hib
vaccine and declining HIV prevalence malaria prevalence has also
declined. The consistency of pneumonia case fatality rates may
thus represent the net effect of multiple factors that we are poorly
placed to understand as surveillance data are inadequate.
Another key requirement in understanding pneumonia mortal-
ity and its variability is potential variation in case-severity.
Variation in patterns of illness severity at presentation may reflect
the prevalence of underlying, biological risk factors in a hospital’s
catchment area but may also capture social, economic, cultural,
and geographic influences on access to services. While there was
clear evidence that children classified as more severely ill had
higher mortality in general failure to classify patients and likely
poor standardization of classification currently make it hard to use
data on case-severity to explain variability in overall inpatient
pneumonia mortality rates.
The interpretation and use of hospital mortality or cause specific
mortality rates to understand health system performance have
been widely debated in the literature. [4] However, there seems
little doubt that we should have access to such basic data. At
present, as in Kenya, this is rarely the case in low income settings.
The data we present serve to demonstrate that variability can be
marked across place while there was less evidence for variation
across time (although data are very limited). Understanding this
variation could help identify location-specific priorities for
intervention and help in assessing efforts to strengthen health
systems. Unfortunately the current scarcity of data reflect
inadequate attention to supporting development of robust, routine
information systems and, we suggest, the result is data that are
inadequate for informed global or national decision making.
Study Strengths and Limitations
Our study compares case fatalities in nine facilities in different
settings and assesses the impact of some important covariates of
mortality. This overcomes the limitation of previous estimates
from single hospitals that did not describe risk factors of mortality.
The data used in this study is based on data of reasonable quantity
and quality in nine sites where staff training in use of guidelines
and structured paediatric admission records were available to
facilitate improved data collection.
However, the findings we report are subject to several
limitations. In common with all studies conducted using routinely
collected data it is difficult to ascertain that a specific or rigorous
case definition for pneumonia was applied by health workers in
routine settings. Separately, failure to classify pneumonia severity
occurred in approximately one in every ten admissions and was
more common in three out of the nine hospitals introducing
possible bias in the study. Between one-third and 81% of patients
Figure 1. Interrupted time series analysis of pneumonia mortality among paediatric admissions to Kilifi District Hospital (1999 to
2008).
doi:10.1371/journal.pone.0047622.g001
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in these three hospitals lacked a classification, resulting in weaker
associations than would be reported if all children had a
pneumonia severity classification. Furthermore data on individu-
als’ HIV status were not available. Such problems could be
overcome by improving approaches to standardising clinical
assessment, documentation and treatment which have already
been explored by other studies in our setting. [13,15] Additional
bias could result from the restricted geographical sampling and
small number of facilities in the study in relation to the total
number of similar facilities in the country. However, our purpose
was not to suggest generalisabilty of a specific finding but more to
illustrate the potential for variation.
The modelling approach, limited by data availability and the
number of hospitals studied, captures multiple possible factors that
may contribute to observed variability within the fixed term for
hospital. Determining which factors are actually important
determinants of variability would require a considerably larger
dataset. Lastly, and of particular relevance to the time series
analysis is the fact that our study was not adequately powered or
designed to detect the impact of routine Hib vaccination on
mortality. To demonstrate such an effect, large carefully designed
studies similar to the assessment of the impact of pneumococcal
vaccination on invasive pneumococcal disease conducted in the
United States using population data from several states need to be
conducted. [20].
Policy Implications and Future Analyses
Despite these limitations the findings of this study are useful The
estimates we report can find application in several areas of
Decision Analysis: (a) as case fatality estimates for modelling effects
of interventions in similar settings where such data is unavailable,
(b) to help define plausible case fatality ranges in sensitivity
analyses, and (c) to address model structure uncertainty when
examining previous models that used simplifying assumptions
about case fatality. In the longer term such models would benefit
from systems in place at regional or national levels to collect basic
clinical and epidemiological data for use in such analyses. [21] The
study, by demonstrating marked variability in pneumonia fatality,
provides a clear challenge to all to explain this. From a health
systems perspective key questions are whether variability in quality
of care, recently identified in a number of studies, or socio-
economic or biological factors are major explanatory factors.
Addressing such questions and evaluating whether interventions
are having an impact will clearly require much better data at
greater scale. Lastly, long term follow-up studies of post discharge
pneumonia mortality are needed but such analysis could not have
been implemented in this study focusing on inpatient outcomes.
Supporting Information
Table S1 Sensitivity analysis of the impact of different
user defined weights for H9 on model estimates of effect
of age, sex, and comorbidity on pneumonia mortality.
(DOC)
Box S1 WHO case definition of pneumonia, severe
pneumonia and very severe pneumonia for children
aged 2 to 59 months. *Nasal flaring, grunting, indrawing,
raised RR
(DOC)
Acknowledgments
The authors gratefully acknowledge the individuals involved in data
collection during the primary study, and the contribution of all persons
working within the paediatric unit of KDH. Our thanks go to Jim Todd
and Elizabeth Allen for advice on analysis and comments on the
manuscript. This paper is published with the permission of the Director,
Kenya Medical Research Institute.
Author Contributions
Conceived and designed the experiments: PA EAO TE RN ME. Analyzed
the data: PA EAO TE. Wrote the paper: PA ME. Read and critically
revised draft manuscripts: PA EAO TE RN ME. Final approval of the
version to be published: PA EAO TE RN ME.
References
1. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, et al. (2010) Global,
regional, and national causes of child mortality in 2008: a systematic analysis.
Lancet 375: 1969–1987.
2. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H (2004) Global estimate of
the incidence of clinical pneumonia among children under five years of age.
Bulletin of the World Health Organization 82: 895–903.
3. Division of health management and information system. Ministry of Public
health and Sanitation. Republic of Kenya (2009) Annual health sector statistics
report 2008.
4. Lilford R, Pronovost P (2010) Using hospital mortality rates to judge hospital
performance: a bad idea that just won’t go away. BMJ 340: c2016.
5. Park RE, Brook RH, Kosecoff J, Keesey J, Rubenstein L, et al. (1990)
Explaining variations in hospital death rates. Randomness, severity of illness,
quality of care. Jama, 264(4):484–490.
6. Rosenthal GE, Shah A, Way LE, Harper DL (1998) Variations in standardized
hospital mortality rates for six common medical diagnoses: implications for
profiling hospital quality. Med Care 36: 955–964.
7. Sinha A, Levine O, Knoll MD, Muhib F, Lieu TA (2007) Cost-effectiveness of
pneumococcal conjugate vaccination in the prevention of child mortality: an
international economic analysis. Lancet 369: 389–396.
8. Ayieko P, Ntoburi S, Wagai J, Opondo C, Opiyo N, et al. (2011) A multifaceted
intervention to implement guidelines and improve admission paediatric care in
Kenyan district hospitals: a cluster randomised trial. PLoS Medicine
8(4):e1001018.
9. English M, Irimu G, Wamae A, Were F, Wasunna A, et al. (2008) Health
systems research in a low-income country: easier said than done. Archives of
disease in childhood 93: 540–544.
10. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, et al. (2005) Bacteremia
among children admitted to a rural hospital in Kenya. NEJM 2005 352: 39–47.
11. Cowgill KD, Ndiritu M, Nyiro J, Slack MP, Chiphatsi S, et al. (2006)
Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction
into routine childhood immunization in Kenya. JAMA 296: 671–678.
12. Lee K (2009) Pneumococcal campaign foreshadows wider initiatives. The
Lancet Infectious Diseases 9: 597.
13. Mwakyusa S, Wamae A, Wasunna A, Were F, Esamai F, et al. (2006)
Implementation of a structured paediatric admission record for district hospitals
in Kenya–results of a pilot study. BMC International Health and Human Rights
6: 9.
14. Demers AM, Morency P, Mberyo-Yaah F, Jaffar S, Blais C, et al. (2000) Risk
factors for mortality among children hospitalized because of acute respiratory
infections in Bangui, Central African Republic. PIDJ 19: 424–432.
15. Berkley JA, Maitland K, Mwangi I, Ngetsa C, Mwarumba S, et al. (2005) Use of
clinical syndromes to target antibiotic prescribing in seriously ill children in
malaria endemic area: observational study. BMJ 330: 995.
16. Newell ML, Brahmbhatt H, Ghys PD (2004) Child mortality and HIV infection
in Africa: a review. AIDS 18 Suppl 2: S27–34.
17. Gove S (1997) Integrated management of childhood illness by outpatient health
workers: technical basis and overview. The WHO Working Group on
Guidelines for Integrated Management of the Sick Child. Bulletin of the World
Health Organization 75 Suppl 1: 7–24.
18. Smyth A, Tong CY, Carty H, Hart CA (1997) Impact of HIV on mortality from
acute lower respiratory tract infection in rural Zambia. Archives of disease in
childhood 77: 227–230.
19. Nokes DJ, Ngama M, Bett A, Abwao J, Munywoki P, et al. (2009) Incidence and
severity of respiratory syncytial virus pneumonia in rural Kenyan children
identified through hospital surveillance. Clin Infect Dis 49: 1341–1349.
20. Centers for Disease Control and Prevention (2005) Direct and indirect effects of
routine vaccination of children with 7-valent pneumococcal conjugate vaccine
on incidence of invasive pneumococcal disease–United States, 1998–2003.
MMWR 54: 893–897.
21. English M, Scott JA (2008) What is the future for global case management
guidelines for common childhood diseases? PLoS medicine 5: e241.
Inpatient Childhood Pneumonia Mortality
PLOS ONE | www.plosone.org 7 November 2012 | Volume 7 | Issue 11 | e47622
